MediciNova, Inc. (MNOV) vs ProMIS Neurosciences, Inc. (PMN)
A side-by-side comparison of MediciNova, Inc. and ProMIS Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MNOV
MediciNova, Inc.
$1.68HealthcareDelayed quote: Oct 6, 2026, 12:56 PM EDT
PMN
ProMIS Neurosciences, Inc.
$9.34HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — MNOV vs PMN
growth of $100 · dividends reinvested · last 10yMNOV -75.0% (-12.9%/yr)PMN -92.2% (-22.5%/yr)MNOV compounded faster over this window
MNOV PMN
MNOV vs PMN: by the numbers
- •PMN is the larger company ($84M vs $82M market cap).
- •Both run net losses; PMN's is the smaller (0.00% vs -1168.20% net margin).
Metrics side by side
Valuation
| Metric | MNOV | PMN |
|---|---|---|
| P/S ratio | 89.57 | N/A |
| P/B ratio | 2.21 | 1.70 |
Profitability
| Metric | MNOV | PMN |
|---|---|---|
| Gross margin | 7.58% | 0.00% |
| Operating margin | -3242.47% | 0.00% |
| Net margin | -1168.20% | 0.00% |
| ROE | -28.85% | -85.48% |
| ROIC | -31.62% | -87.79% |
Growth (annualized)
| Metric | MNOV | PMN |
|---|---|---|
| Revenue CAGR (5Y) | -25.46% | N/A |
| Total return CAGR (5Y) | -13.62% | -47.05% |
Frequently asked
- How have MNOV and PMN total returns compared?
- Over the past 10 years, MNOV delivered -13.11% and PMN delivered -22.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.